Eli Lilly Neutralizing Antibodies: Breakthrough for COVID-19 Treatment?

September 18, 2020 04:00am

Eli Lilly stated LY-CoV555 was “well tolerated” without the observation of any drug-related serious events. And that adverse events were similar to placebo. However, the exact incidence of milder drug reactions which could affect patient acceptance were not given.

Q&A: How Direct to Business Coverage Can Help Infection Care
Bug of the Month: I Can Be Deadly for Cystic Fibrosis Patients
Visiting Hours: Time to Re-evaluate Restrictions Caused by COVID
How This Vascular Access Nurse Relies on an Infection Preventionist

Taking Aim at Antibiotic-Resistant Bacteria During COVID

September 16, 2020

Patients afflicted with COVID-19 have an increased susceptibility to antibiotic resistant infections both from prolonged hospitalizations and the use of immunocompromising agents such as dexamethasone.

Q&A: Infection Preventionists Should Head Back to School

September 16, 2020

Kevin Kavanagh, MD: “I think you’ll find that infection preventionists in this type of climate are just not healthcare employed personnel. They need to be everywhere. They need to be in business. They need to be in schools. And, of course, they need to be in our healthcare system. But it is crucial to be in schools…”

Expanding Size, Variety of Infection Prevention Team Pays Off

September 16, 2020

Diversifying roles and creating support staff benefits the team by increasing the productivity of the department and providing a deeper bench so that IPs can focus on broader activities requiring specific subject matter expertise.

UVC Light: Powerful Disinfectant, But Not Easy to Use

September 14, 2020

The effectiveness of UVC for reduction of microorganisms including bacteria, viruses, and fungi has been proven time and again. But using UVC radiation to disinfect is not simple and requires lots of protocols to use safely.

Spray-On Personal Protective Equipment in the Works

September 11, 2020

Peter Walter, PhD: “We think of AeroNabs as a molecular form of PPE that could serve as an important stopgap until vaccines provide a more permanent solution to COVID-19.”